Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors

Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors

Introduction. The role of autologous hematopoietic stem cell transplantation (autoHSCT) in adult patients with acute myeloid leukemia (AML) with poor prognosis factors is not completely defined.Purpose: to present the results of a multicenter prospective study of autoHSCT efficacy in AML patients wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. D. Petrova, K. N. Melkova, N. V. Gorbunova, T. Z. Chernyavskaya, V. A. Doronin, V. N. Kostrykina, O. P. Trofimova, I. Yu. Grivtsova, N. N. Tupitsyn
Format:	Article
Language:	Russian
Published:	ABV-press 2016-03-01
Series:	Онкогематология
Subjects:	acute myeloid leukemia autologous hematopoietic stem cells transplantation total body irradiation unfavorable prognostic factors
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/183
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia
by: N. P. Kirsanova, et al.
Published: (2022-11-01)

Classification of Conditioning Regimens for Bone Marrow Transplantation: Historical Background and Current Perspectives
by: KN Melkova, et al.
Published: (2017-10-01)

Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data
by: A. V. Popova, et al.
Published: (2025-03-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Epidemiology of bacteremia after autologous hematopoietic stem cell transplantation in the absence of antibiotic prophylaxis
by: Rima Moghnieh, et al.
Published: (2018-02-01)

Application of autologous hemopoietic stem cells in inoperable patients with chronic critical lower limb ischemia
by: I. P. Mikhaylov, et al.
Published: (2022-04-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma
by: V. I. Mazurov, et al.
Published: (2022-07-01)

CLASSIFICATION OF UNFAVORABLE OUTCOMES OF THE PERI-OPERATIVE PERIOD
by: D. V. Sаdchikov, et al.
Published: (2019-01-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Autologous stem cell transplantation in the treatment of Hodgkin's disease
by: Tarabar Olivera, et al.
Published: (2009-01-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience
by: N. E Mochkin, et al.
Published: (2025-03-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013-02-01)

The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience
by: N. V. Zhukov, et al.
Published: (2014-09-01)

Forecasting index of unfavorable outcomes of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2021-06-01)

Cardiopulmonary exercise testing in patients with precapillary pulmonary hypertension with an unfavorable prognosis
by: A. V. Berezina, et al.
Published: (2024-10-01)

Recent advancements in hematopoietic stem cell transplantation in Taiwan
by: Chi-Cheng Li, et al.
Published: (2024-01-01)

Current status of hematopoietic stem cell transplantation in Russia
by: L. P. Mendeleeva, et al.
Published: (2022-11-01)

Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
by: Ida Erngren, et al.
Published: (2025-07-01)

Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery
by: NE Mochkin, et al.
Published: (2018-07-01)

Clinical factors associated with unfavorable outcomes in HIV-positive tuberculosis patients
by: V. S. Borovitskiy, et al.
Published: (2021-11-01)

Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases
by: VO Sarzhevskii, et al.
Published: (2017-01-01)

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation
by: FU Xiaoyan, et al.
Published: (2025-07-01)

Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation
by: S. V. Semochkin, et al.
Published: (2024-09-01)

Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas
by: Yu. L. Shevchenko, et al.
Published: (2014-07-01)

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients
by: M. V. Solovev, et al.
Published: (2019-01-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

Comparison of the efficacy of chemotherapy and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first remission in adults
by: S. N. Bondarenko, et al.
Published: (2015-09-01)

RHEUMATOID ARTHRITIS WITH SYSTEMIC MANIFESTATIONS: DIAGNOSIS, INDICATORS OF AN UNFAVORABLE COURSE
by: B D Nazarov, et al.
Published: (2012-12-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
by: VO Sarzhevskii, et al.
Published: (2016-10-01)

Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma
by: S. V. Semochkin, et al.
Published: (2023-12-01)

Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors
by: Marjanović Slobodan, et al.
Published: (2005-01-01)

Determinants of an unfavorable treatment outcome among tuberculosis patients in the Jimma Zone, Southwest Ethiopia
by: Berhane Megerssa Ereso, et al.
Published: (2024-11-01)

Autologous hematopoietic stem cell transplantation as a method of immune prevention of type 1 diabetes mellitus: possibilities and prospects
by: M. E. Chernaya, et al.
Published: (2024-07-01)